CME Group, Inc. (CME) Tops Q3 EPS by 10c; Updates FY11 Op Expenses Outlook
Tweet
Share
E-mailGet Alerts CME Hot Sheet
Price: $267.21 +1.92%
Financial Fact:
Income tax provision: 76M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income tax provision: 76M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
CME Group, Inc. (NASDAQ: CME) reported Q3 EPS of $4.74, $0.10 better than the analyst estimate of $4.64. Revenue for the quarter came in at $874 million versus the consensus estimate of $875.55 million.
The company expects 2011 operating expenses of between $1.23 billion and $1.235 billion.
The company expects 2011 operating expenses of between $1.23 billion and $1.235 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- CME Group Foundation Invests $360K in First-Generation Illinois Scholars
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
